# Ubie

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ubie

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: https://ubie.life
- Total disclosed funding: $59M
- Latest round: Series C (Dec 8, 2022)
- Investors on record: 11

## About

Founded in 2017 by co-founders Yoshimichi Abe and Kota Kubo and based in Tokyo, Japan, Ubie, Inc. engages in the development and operation of a mobile application that detects early stages and diagnose diseases from patients' symptoms. The company utilizes artificial intelligence to provide information about causes, severity, and treatment recommendations. In October 2025, Ubie Inc. raised JPY 1 billion in venture debt funding from returning investor Shoko Chukin Bank. The company provides a free symptom search engine app called Ubi. The app allows users to answer doctor-supervised questions about their symptoms and receive information on related diseases, treatment options, and nearby medical facilities. Additionally, Ubie Medical Navi is an AI-powered questionnaire and communication suite of solutions for medical institutions to improve efficiency in areas like patient intake and reception, as well as enhance patient recognition. Ubie connects pharmaceutical companies with consumers and healthcare providers through their medical platform. This service raises awareness of specific diseases and treatments, promoting earlier diagnoses and appropriate medical care. The company will use the May 2025 funding for overseas expansion, and the development and growth of its business.

## Funding rounds

- Series C, Dec 8, 2022, $19M — Rakuten Capital, Asia Africa Investment & Consulting, Sogo Medical Group Co., Ltd., Shinsei Impact Investment
- Series C, Oct 6, 2022, $14M — Rakuten Capital, Sogo Medical Group Co., Ltd., AAIC Holdings, Shinsei Impact Investment
- Series C, Jul 27, 2022, $26M — Dai-ichi Life Insurance, SUZUKEN CO., LTD., Norinchukin Capital, EggForward, NVenture Capital
- Seed, Sep 1, 2017, $0.6M — D4V

## Investors

- D4V (https://capitalatlas.ai/funds/d4v) — Seed
- Dai-ichi Life Insurance — Series C
- SUZUKEN CO., LTD. — Series C
- Norinchukin Capital (https://capitalatlas.ai/funds/norinchukin-capital) — Series C
- EggForward — Series C
- NVenture Capital (https://capitalatlas.ai/funds/nventure-capital) — Series C
- Rakuten Capital (https://capitalatlas.ai/funds/rakuten-capital) — Series C
- Sogo Medical Group Co., Ltd. — Series C
- AAIC Holdings — Series C
- Shinsei Impact Investment (https://capitalatlas.ai/funds/shinsei-impact-investment) — Series C
- Asia Africa Investment & Consulting (https://capitalatlas.ai/funds/asia-africa-investment-consulting) — Series C